Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore immunomodulatory and immunosuppressive mechanisms of
action of fingolimod in patients with Relapsing remitting multiple Sclerosis to collect data
on biomarkers after initiation of fingolimod treatment.